IL2 and myeloid sarcoma: The overall Th1 and Th17 cells but not GM-CSF co-expressing Th1 and Th17 cells were also suppressed by the anti-IL-12 and by the anti-IL-2 plus anti-IL-12 antibodies in PBMC from both HC and MS patients (Figure S6).